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Background: Chikungunya virus is a re-emerging pathogen that is responsible for Chikungunya fever periodic 
outbreaks along the Kenyan coast and in other African countries.  Epidemiological data from the World Health 
Organization show that in 2014-2015, there was a major outbreak of Chikungunya fever in the Americas and Pacific 
Islands.  Surveillance and correct diagnosis are therefore key in controlling the spread and management of the 
disease. 
Plaque and focus assays are key techniques in viral characterization or quantification, and both assays typically 
require overlay with gelling polymers to limit the spread of viruses in cell culture.  There are anecdotal reports that 
Avicel may be superior to methylcellulose in assay of Influenza virus. However, it is unclear whether this would apply 
to other viruses. 
Objective: The objective of this study was to determine the performance of methylcellulose and Avicel overlays in 
plaque and focus assays of Chikungunya virus. 
Methods: Confluent Vero cells were seeded in 6- or 96-well plates for plaque and focus assays respectively. Cells were 
inoculated with serially diluted Chikungunya virus, and incubated to allow adherence of the virus to the cells. The 
inoculum was removed; replaced with Avicel or methylcellulose overlay at various concentrations and stained with 
crystal violet or immunostained.  Statistical significance was computed using the Holm-Sidak test. 
Results: The size of plaques formed by Chikungunya virus was dependent on the concentration of both Avicel and 
methylcellulose gels used as overlays, with Avicel overlays giving consistently larger plaques than methylcellulose.  
Chikungunya virus formed plaques nearly 2.5 times larger in diameter (2 vs 0.8 mm) with 1.2 % Avicel than with 1.25 
% methylcellulose after 60 hr growth.  Plaques formed with Avicel were better defined and easier to count after 48 hr 
growth period compared to a 60 hr period. However, methycellulose overlays provided smaller, more distinct and 
better defined foci in focus assays. 
Conclusion: Both methylcellulose and Avicel are good overlay media for viral assays. Avicel is marginally better for 
plaque assays while methylcellulose provides more distinct and easier to count foci in focus assays. 
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1. Introduction 
Chikungunya virus (CHIKV) is an arthropod-borne 
alphavirus that belongs to the Togaviridae family, and is 
responsible for sporadic worldwide outbreaks of 
Chikungunya fever (CHIKF) (Charrel et al, 2007; Nasci, 
2014).  
According to the World Health Organization (WHO), 
there was in 2014/2015 a CHIKF outbreak in the 
Americas and Pacific Islands, affecting more than 40 
countries, with more than 1 million suspected cases 
(Leparc-Goffart et al, 2014; Khan et al, 2014; WHO, 
2015).  
CHIKV is primarily transmitted to humans through the 
bite of infected female Aedes mosquitoes (Jupp and 
McIntosh, 1988). Early Chikungunya fever symptoms 
include high fever, myalgia, headache and rashes. These 
are followed in the late phase by intense arthralgia, 
severe headaches, seizures, sensory abnormalities and 
motor dysfunction that gives a characteristic contorted 
posture (or chikungunya in the Kimakonde language), 
from which the disease derives its name (Tournebize et 
al, 2009; WHO, 2015).  
Chikungunya fever is an important emerging infection 
in tropical Africa, south-east Asia, central and south 
America, with no antiviral medicines nor vaccines yet 
available.  Diagnosis and surveillance of CHIKV are 
essential to prevent its spread, but are challenged by 
insufficient availability of cost effective diagnostic tools 
and treatment options (Chipwaza et al, 2014; WHO, 
2015). High through-put methods for viral 
quantification are therefore essential in supporting 
development of novel treatments, vaccines and 
diagnostic tools.  
CHIKV infectious particles can be quantified using 
plaque assays to measure its cytopathic effect (CPE) in 
high through-put 96-well microtitre plates. Plaque 
assays are the standard method for quantifying viral 
infectious particles (Pickard et al, 2009).  A viral plaque 
is a clear area of lysed cells formed by viruses growing 
on a monolayer of confluent host cells.  Plaques are 
useful for the determination of viral titre of a liquid 
sample, as each plaque represents an infectious virus 
particle. For viruses that do not lyse cells, or to avoid 
the long infection times required for plaque assays, 
focus assays can be performed. In focus assays, viral 
antigens expressed by host cells are immunostained 
with labelled antibodies, and foci (rather than plaques) 
are visualized and counted (Flint et al, 2009). 
During plaque assays, a confluent monolayer of host 
cells is infected with serially diluted viral samples, and 
the host cells are covered with an overlay medium to 
limit the spread of the viral particles.  The overlay 
medium is typically made of semi-solid or gel forming 
polymers such as agarose, agar, methylcellulose or 
Avicel with sufficient viscosity to optimally reduce viral 
diffusion. The choice of overlay medium is thus critical 
for the success of the assay, and in this regard, 
Matrosovich et al (2006) demonstrated that Avicel was 
superior to methylcellulose and agar overlays for 
Influenza viral plaque and focus assay. In this study, we 
compared the performance of methylcellulose, a 
commonly used overlay medium, and Avicel as overlay 
media in CHIKV plaque and focus assays. 
2. Materials and Methods 
2.1 Viruses and Cells 
Vero cells (American Type Culture Collection - ATCC, 
CCL81) were cultivated in single strength Eagle’s 
Minimum Essential Medium (EMEM) (Gibco, Paisley, 
UK) supplemented with  2 % L-Glutamine (Sigma-
Aldrich, St. Louis, USA), 10 % Fetal Bovine Serum 
(Sigma, St. Louis, USA), 2 % Penicillin-Sterptomycin 
(Penicillin 1000 U/mL, Streptomycin 10mg/mL(Sigma-
Aldrich, St. Louis, USA) and 1 % non-essential amino 
acids (Gibco, Paisley, UK). Cells were incubated at 37oC 
till a 90 %-confluent monolayer was observed. 
Chikungunya virus (CHIKV strain Lamu 33) is a well 
characterized strain isolated from a patient from Lamu, 
Kenya during the 2004 Chikungunya outbreak (Kariuki 
Njenga et al, 2008). To obtain viral stock, confluent 
monolayers of Vero cells  in 75 cm2 culture flasks were 
infected with CHIKV, incubated at 37 ºC under a 5%  
CO2 atmosphere and harvested on Day three when 
about  90 % of CPE was attained. The infected culture 
fluid (ICF) was harvested by centrifuging at 600 g for 10 
min in a refrigerated centrifuge (TOMY Model AX-311, 
Tokyo, Japan), and the supernatant (the viral stock) 
aliquoted and stored at - 80°C. 
2.2 Infection of cells for plaque and focus assays 
Tenfold serial dilutions (1x101 to 1x107) of the virus 
stock were prepared in EMEM containing 2 % Fetal Calf 
Serum and inoculated into their respective wells in 6-
well or 96-well plates seeded with 90% confluent 
monolayer of Vero cells.  The plates were incubated at 
37 oC in a 5% CO2 incubator for 90 min to allow 
adherence of the virus to the cells. The inoculum was 
removed by aspiration and replaced with 3 ml of Avicel 
or methylcellulose overlay at various concentrations. 
The plates were incubated for 60 and 28 hr for plaque 
and focus assays respectively. Plaques were stained 
with 1 % crystal violet stain after fixing with 3.7 % 
formaldehyde for 2 hr at room temperature. The foci 
were immunostained with 3,3’-Diaminobenzidine 
(DAB). Wells were photographed by Nikon camera and 
the images were acquired in Adobe Photoshop software 
(Adobe Systems Inc., San Jose, CA, USA).  
2.3 Statistical Analysis.  
Statistical analysis was performed using GraphPad 
Prism 6 (GraphPad Software Inc., San Diego, USA). 
Comparisons of radial dimensions of viral plaques and 
foci were done using the Holm-Sidak repeated-
measures analysis of variance (Holm, 1979).  A p value 
of < 0.05 was considered significant. 
2.4 Ethical considerations 
This study was approved by the Kenyatta National 
Hospital and University of Nairobi Ethics and Research 
Review Committee (Ref No: KNH-ERC/A/132). 
3.  Results  
Plaques are formed by localized damage of host cells 
due to growth of the virus from one progenitor virus. 
The destroyed cells do not take up the crystal violet 
stain, and remain as clear zones upon staining.  The size 
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of the plaques is dependent upon the rate of spread of 
growing virus to the surrounding cells, which is in turn 
limited by the viscosity of the overlay medium. In the 
absence of any overlay, the progeny viruses migrate to 
the surrounding host cells; there is consequently no 
localized damage, and no plaques are formed.   
Our results show that the size of plaques formed by 
CHIKV were inversely proportional to the concentration 
of both Avicel and methylcellulose gels used as overlays. 
Under 0.6 % Avicel overlay CHIKV formed plaques 
nearly 3 times larger in diameter (3 vs 1.2 mm; p = 
0.0001) than under 1.6 % Avicel after 48hr growth 
(Figure 1). 
Viral plaques formed under methylcellulose were 
considerably smaller in diameter than those under 
Avicel across all the concentrations tested (0.3, 0.6, 1.2 
and 1.6% for Avicel versus 1.2 and 1.6% for 
methylcellulose); with the largest plaques obtained 
under methylcellulose overlay about two times smaller 
than the smallest plaque size obtained under Avicel 
(plaques of 0.71 mm diameter with 1.2% 
methylcellulose vs 1.2 mm with 1.6 % Avicel; p = 
0.0001). The plaque sizes under methylcellulose 
showed little variation at 1.2 and 1.6 % concentration 
(0.71 vs 0.67 mm diameters; p = 0.003). 
Morphologically, the plaques obtained with both 
overlays were rounded and clear areas surrounded by 
the purple region that took up the crystal violet stain 
(Figure 1).   
In the focus assays, the foci formed under 
methylcellulose overlay appeared as dark brown and 
uniformly stained opaque circular spots against a pale 
brown translucent background. The edges of foci 
obtained with methylcellulose overlay were sharper 
and more distinct than those formed under Avicel, 
which tended to have speckled focal areas with uneven 
edges (Figure 1). 
 
A. Vero cells were infected with CHIKV Lamu 33 Strain. Cells were stained with 1 % crystal violet dye and diameter of plaque 
diameters measured for various dilutions of Avicel overlay suspension.  The plaque diameter changed inversely to increased 
concentration of Avicel.  
B. Parallel plaque assays at viral titres of 10-6 in 6-well plates under Avicel 1.2 % (B1) and methylcellulose 1.2% (B2).  
C. Parallel plaque assays at viral titres of 10-4 in 6-well plates under Avicel 1.2 % (C1) and methylcellulose 1.2% (C2). Plaques 
formed under Avicel were generally larger in diameter.  
D. Parallel focus assays at viral titres of 10-6 in 96-well plates using Avicel 1.2% (D1) and methylcellulose 1.2% (D2).  Viruses 
were immunostained with DAB.  
E. Parallel focus assays at viral titres of 10-4 in 96-well plates using Avicel 1.2 % (E1) and methylcellulose 1.2% (E2). Viruses 
were immunostained with DAB. 
Figure 1: Performance of methycellulose and Avicel overlays for plaque and focal assay of Chikungunya virus. 
Performance was evaluated as plaque diameter and distinctness of focal areas.  
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4. Discussion 
Our results demonstrate that Avicel performed better 
than methylcellulose overlay in plaque assays as it 
provided consistently larger plaques which are easier to 
count.  Methylcellulose overlay was, however, more 
reliable in focus assays, yielding well defined foci, and is 
therefore more suitable for focal assays in 96 well 
plates.  The differential performance of overlay media 
has been observed by other researchers as well. For 
example Herzog et al (2008) showed that Avicel overlay 
was more suitable for human corona virus plaque 
assays as it formed larger plaques while agarose overlay 
was more suitable for purification of the virus. The 
variations in the performance of different overlay media 
could be attributed to the nature of the virus and the 
host cells, as the infectivity of a virus depends on its 
virulence factors and the receptors on the cell 
membrane of the host cells. A high the rate of 
adsorption of a virus to the host cells, leads to the large 
radial dimension of viral plaque (Koch, 1964; Alvarez et 
al, 2007). Other factors that may affect the diameter of 
the plaques and foci include the density and viscosity of 
the overlay media (Randhawa et al, 1977; Abedon and 
Yin, 2009). Thus, McKimm-Breschkin (2004) found that 
carboxymethylcellulose based overlays gave 
comparatively smaller plaques than agarose when used 
for plaque assays of respiratory syncytial virus (RSV). 
5. Conclusion 
Our results demonstrate that Avicel overlay performed 
better in Chikungunya plaque assays, giving 
consistently larger plaques that were easier to count. On 
the other hand, methylcellulose overlay was more 
suitable for focus assays as it provided sharply defined 
and distinct focal areas. We therefore recommend 
Avicel overlay for CHIKV plaque assays and 
methylcellulose for focus assays. 
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